On Thursday, 12th March, NHS England published updated guidance to primary care about unregulated providers supplying hormone medications to transgender children and young people.
This guidance is harmful, and we are naming it as such.
Let us be clear: this guidance does not protect children. NHS England now does not offer any gender affirming medical care for trans youth, and this guidance is their attempt to ensure private healthcare is also out of reach.
It does this, not on the basis of sound clinical evidence, but as part of a sustained, politically driven effort to eliminate affirmative care from the healthcare landscape, step by step. This guidance is another manoeuvre to achieve that, and we refuse to pretend otherwise.
The NHS is not the gold standard for trans+ healthcare. That is not a controversial statement; it’s simply true. And we are not going anywhere.
Read our long read on how the NHS is failing trans+ young people, and what it means for families in the UK